Vertex Pharmaceuticals

NASDAQ: VRTX · Real-Time Price · USD
392.76
2.46 (0.63%)
At close: Aug 15, 2025, 3:59 PM
392.79
0.01%
After-hours: Aug 15, 2025, 06:16 PM EDT

Vertex Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
1.03B 646.3M 913M 1.05B -3.59B 1.1B 968.8M 1.04B 915.7M 699.8M 818.9M 930.5M 810.5M 762.1M 770.11M 851.93M 66.92M 653.14M
Depreciation & Amortization
51.7M 48.4M 46.5M 53.2M 54M 53.5M 59M 42.1M 41.4M 38.8M 38.4M 36.7M 37.3M 35.9M 33.83M 31.7M 31.24M 28.83M
Stock-Based Compensation
167.3M 166.1M 167.8M 184.6M 154.2M 191.9M 208.6M 130.9M 119.3M 122.4M 111.5M 135.6M 113.9M 130.3M 118.61M 103M 104.62M 115.17M
Other Working Capital
27M 42M -490.1M 325.7M -244.2M 460.9M -752.5M 283.3M 285.5M 276.3M -182.7M 297M 455.8M 144.9M 151.25M 109.79M -178.57M 147.94M
Other Non-Cash Items
67.4M 418.2M -34.1M 52.4M -8M -9.4M -31.9M -13.3M -10.8M 13.4M 52.4M -45.8M 23.8M 73M -20.3M -36.08M -155K 50.73M
Deferred Income Tax
-113.8M -191.6M 51.6M -123.3M -118.8M -158.3M -131M -115.5M -176.6M -113.4M 148.1M -182.3M -229.4M -12.3M -41.95M 68.24M -237.94M 57.04M
Change in Working Capital
-132.4M -268.5M -560.2M 157.5M -241.4M 129.3M -838.9M 188.9M 245.4M 138.9M -90.9M 80.8M 383.7M -32.8M 134.68M -91.56M -164.46M 16.14M
Operating Cash Flow
1.07B 818.9M 584.6M 1.37B -3.75B 1.31B 234.6M 1.27B 1.13B 899.9M 1.08B 955.5M 1.14B 956.2M 994.99M 927.22M -199.77M 921.05M
Capital Expenditures
-145.7M -40.7M -92.6M -67.7M -76.7M -248.4M -58.1M -40.6M -59.6M -42.1M -33.6M -54.2M -53.3M -63.6M -61.8M -52.4M -49.9M -70.9M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 10M -0.00 77M n/a n/a n/a
Purchase of Investments
-2.17B -1.65B -2.16B -1.13B -1.55B -2.6B -988.5M -407.2M -549.3M -1.84B -274.9M -227.7M -120.8M -117.1M -119.45M -246.29M -118M -121.45M
Sales Maturities Of Investments
1.84B 1.64B 1.46B 1.11B 1.18B 710.5M 218.1M 331.2M 334.9M 50M 484.1M 193.6M 112.6M 129.7M 47.17M 230.86M 103.2M 118.07M
Other Investing Acitivies
-4.3M -5.3M -30.9M -266.1M -22.7M -180M -58M -1.1M -29.9M n/a n/a -295.9M -10M n/a -77M 15M -15M n/a
Investing Cash Flow
-484.5M -55.8M -821.9M -348M -463.7M -2.14B -886.5M -117.7M -303.9M -1.83B 175.6M -384.2M -61.5M -51M -134M -52.95M -79.64M -74.31M
Debt Repayment
-1.3M -1.3M -1.3M -5.4M -13.7M -13.2M -12M -11.3M -11M -10.6M -10.4M -49.5M -12.7M -12.9M -2.46M -11.1M -2.31M -8.6M
Common Stock Repurchased
-397.7M -696.6M -425.2M -391.4M -400.8M -364.7M -152.7M -170.2M -31.4M -299.4M -2.1M -48M -4.4M -117.5M -369.85M -660.8M -3.6M -424.95M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
49.8M 17.5M 35.2M 9.3M 55.9M 20.4M 44.9M 16.5M 59.7M 15.3M 52.7M 37.3M 64.8M 35M -316K 15.24M 39.51M -100.66M
Financial Cash Flow
-349.2M -680.4M -391.3M -387.5M -358.6M -357.5M -119.8M -165M 17.3M -294.7M 40.2M -60.2M 47.7M -95.4M -336.24M -656.66M 33.55M -518.65M
Net Cash Flow
296.6M 113.2M -675.9M 657.1M -4.58B -1.2B -744.3M 963.2M 857.8M -1.22B 1.33B 472.9M 1.1B 803.9M 519.89M 209.15M -241.84M 324.06M
Free Cash Flow
927.4M 778.2M 492M 1.3B -3.83B 1.06B 176.5M 1.23B 1.07B 857.8M 1.04B 901.3M 1.09B 892.6M 933.2M 874.8M -249.6M 850.1M